Bioceres Crop Solutions BIOX
NASDAQ BIOX
$0.42 -0.01 (-2.65%)
As of: Sep 10, 2026 · 12:57 PM EDT

Bioceres Crop Solutions (BIOX) Cash from Restructuring (2021 - 2025)

Bioceres Crop Solutions' (BIOX) quarterly Cash from Restructuring came in at $661970.0 in Q4 2025, up 2.98% quarter-over-quarter from $642844.0 in Q3 2025.

Analysis

Bioceres Crop Solutions (BIOX) Cash from Restructuring (2021 - 2025) Analysis & Trends

Bioceres Crop Solutions has disclosed Cash from Restructuring across 3 years of filings, most recently posting $661970.0 for Q4 2025.

  • In Q4 2025, Cash from Restructuring changed N/A year-over-year to $661970.0; the TTM figure through Dec 2025 stood at -$144044.0 (changed N/A YoY), while the FY2022 annual figure was -$724429.0, changed N/A from the prior year.
  • Cash from Restructuring came in at $661970.0 for Q4 2025 at Bioceres Crop Solutions, up from $642844.0 in the prior quarter.
  • In the past five years, Cash from Restructuring ranged from a high of $661970.0 in Q4 2025 to a low of -$724429.0 in Q3 2021.
  • Average Cash from Restructuring over 3 years is -$173694.6, with a median of -$724429.0 recorded in 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Corteva 56.66 Bn 54.29 Bn 3.66 Bn
2 Fmc 1.52 Bn 1.04 Bn 342.10 Mn
3 Cibus 121.89 Mn 101.46 Mn -
4 American Vanguard 64.89 Mn 20.99 Mn 34.71 Mn
5 Bioceres Crop Solutions 26.25 Mn 11.35 Mn 12.70 Mn
6 Genvor 25.12 Mn 24.93 Mn -
7 Origin Agritech 7.83 Mn 4.26 Mn -
8 SenesTech 4.63 Mn -449,048.42 567,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 661,970.00
Sep 30, 2025 642,844.00
Mar 31, 2022 -724,429.00
Dec 31, 2021 -724,429.00
Sep 30, 2021 -724,429.00